Joseph H. Griffith IV

Chief Financial Officer and Treasurer 908 Devices

Last Reviewed: September 28, 2026

Executive Summary

Joseph H. Griffith IV is Chief Financial Officer and Treasurer of 908 Devices, the Nasdaq-listed company based in Burlington, Massachusetts. It makes handheld devices that use mass spectrometry and optical spectroscopy to analyse chemicals at the point of need, in applications such as fentanyl and illicit drug detection, toxic exposure and security threats. He joined as CFO in March 2014, the same year the company launched its first device, and has stayed in the role through its public listing and a portfolio reshaping that took it out of desktop bioprocessing instruments. He spent the decade before that in finance at laboratory instrument companies, rising from controller to chief accounting officer at Caliper Life Sciences and then serving as a business unit CFO at PerkinElmer. He trained at Arthur Andersen and is a licensed CPA.

Career Highlights

• Chief Financial Officer and Treasurer of 908 Devices since March 2014. He certified its Q2 2026 quarterly report as principal financial officer in August 2026.
• Chief Financial Officer of PerkinElmer’s Life Sciences and Technology business unit, November 2011 to March 2014.
• Chief Accounting Officer and Vice President of Finance of Caliper Life Sciences, April 2008 to November 2011, after five years as its Corporate Controller. PerkinElmer later acquired Caliper.
• Corporate Controller of Zymark Corporation, a laboratory automation company, from 2002 until Caliper acquired it in 2003.
• Audit Senior at Arthur Andersen, 1997 to 2002. Licensed Certified Public Accountant.

Professional Journey

Griffith started his career in audit at Arthur Andersen, where he worked from August 1997 to February 2002. He then moved into corporate finance as Corporate Controller of Zymark Corporation, a maker of laboratory automation, robotics and liquid handling systems. When Caliper Life Sciences acquired Zymark in July 2003, he became Caliper’s Corporate Controller. He was promoted to Chief Accounting Officer and Vice President of Finance in April 2008. After PerkinElmer acquired Caliper, he served from November 2011 as Chief Financial Officer of PerkinElmer’s Life Sciences and Technology business unit.

In March 2014 he left to become Chief Financial Officer and Treasurer of 908 Devices, which was then developing its first handheld mass spectrometry device. According to its 10-K, the company has since sold more than 3,700 handheld devices to over 700 customers. In recent years it has narrowed its focus to handheld chemical detection for health, safety and defense customers. In March 2025 it sold its desktop portfolio to Repligen. In June 2025 it moved manufacturing from Boston to Danbury, Connecticut, and it cut its workforce by about 11%. In May 2026 it completed the acquisition of NIRLAB, a Swiss developer of near-infrared spectroscopy for instant material identification. The company reported total revenue of $56.2 million for 2025.

He remains CFO. The April 2026 proxy lists him as Chief Financial Officer and Treasurer, and he signed the company’s certification for the quarter ended 30 June 2026.

Education

Villanova University

B.S., Accounting